Instrument Inactif

Communiqués KaloBios Pharmaceuticals Inc Nasdaq

Actions

US48344T1007

Produits pharmaceutiques

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

12/07/24	Humanigen, Inc. a cessé ses activités	CI
01/05/24	Audience combinée pour l'approbation de la déclaration d'information et du plan pour Humanigen, Inc.	CI

Communiqués

17/12	Humanetics Corporation Appoints Timothy E. Morris as Chief Operating Officer	AQ
19/04/23	HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
06/04/23	HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	AQ
30/03/23	HUMANIGEN, INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
13/03/23	HUMANIGEN, INC : Regulation FD Disclosure (form 8-K)	AQ
02/03/23	HUMANIGEN, INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
24/02/23	HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22/12/22	HUMANIGEN, INC : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	AQ
14/11/22	HUMANIGEN, INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
24/10/22	CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Humanigen Investors of a Lead Plaintiff Deadline of October 25, 2022	PR
20/10/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
13/10/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
06/10/22	HUMANIGEN, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	AQ
06/10/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
03/10/22	CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Humanigen Investors of a Lead Plaintiff Deadline of October 25, 2022	PR
29/09/22	HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
29/09/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
22/09/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
19/09/22	CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Humanigen Investors of a Lead Plaintiff Deadline of October 25, 2022	PR
15/09/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
12/09/22	CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Humanigen Investors of a Lead Plaintiff Deadline of October 25, 2022	PR
08/09/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
02/09/22	HUMANIGEN, INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
01/09/22	HGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	PR
30/08/22	HUMANIGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Humanigen, Inc. and Encourages Investors to Contact the Firm	BU